NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
Inventory
NeoPharm Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Inventory
₩14.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
|
|
AmorePacific Corp
KRX:090430
|
Inventory
₩463.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
Amorepacific Group
KRX:002790
|
Inventory
₩532.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
Cosmax Inc
KRX:192820
|
Inventory
₩253B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
12%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Inventory
₩832.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Inventory
₩452.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
25%
|
|
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
What is NeoPharm Co Ltd's Inventory?
Inventory
14.4B
KRW
Based on the financial report for Sep 30, 2025, NeoPharm Co Ltd's Inventory amounts to 14.4B KRW.
What is NeoPharm Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
14%
Over the last year, the Inventory growth was -2%. The average annual Inventory growth rates for NeoPharm Co Ltd have been 12% over the past three years , 12% over the past five years , and 14% over the past ten years .
